An oncologist is defined as a veterinarian who specializes in the diagnosis and treatment of cancer in animals.
PORTLAND, OREGON, UNITED STATES, October 21, 2022 /EINPresswire.com/ — As per the report published by Allied Market Research, the global veterinary oncology market was accounted for $297.30 million in 2020, and is estimated to garner $819.84 million by 2030 , growing at a CAGR of 10.8% from 2021 to 2030.
The
https://www.alliedmarketresearch.com/request-sample/7504
An oncologist is defined as a veterinarian who specializes in the diagnosis and treatment of cancer in animals. Cancer is one of the leading causes of death in pets, especially dogs and cats. Animals such as cats and dogs suffer from many types of cancer, such as skin tumors. A veterinarian diagnoses cancer in animals, determines the structure of the tumor and plans treatment and administration of chemotherapy. Surgery, chemotherapy, immunotherapy and radiation therapy are the most common oncological treatments in animals.
Major market players covered in the report, such as –
Accuray Incorporated
Boehringer Ingelheim International GmbH
Elanco
Karyopharm Therapeutics, Inc.
Morphogenesis, Inc.
Nippon Zenyaku Kogyo Co.
PetCure Oncology
Regeneus Ltd.
Varian Medical Systems, Inc.
Zoetis
Key benefits for stakeholders –
• The report provides quantitative analysis of market segments, current trends, strategies and potential of veterinary oncology market research to identify potential veterinary oncology market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided. • Porter’s Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global veterinary oncology market analysis, key players, market segments, application areas and market growth strategies.
♦ 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧:
https://www.alliedmarketresearch.com/request-for-customization/7504
Growth of the veterinary oncology market is attributed to factors such as advancement in R&D activities for veterinary cancer therapy; rise in prevalence of cancer such as lymphoma, skin cancer, and mammary cancer in animals (mostly in dogs and cats); increase in funds from private & government organizations for development of various veterinary cancer centers and rise in awareness about pet illness. The veterinary oncology market gains interest in pet drug manufacturing companies, owing to surge in demand for oncology treatment therapy. This leads to increase in adoption of veterinary cancer therapy.
TABLE OF CONTENT –
CHAPTER 1 – INTRODUCTION:
1.1. Report description
1.2. Key market segments
1.3. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 – EXECUTIVE SUMMARY:
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3 – MARKET OVERVIEW:
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis/Top Player Positioning
3.4. Porter’s Five Forces Analysis
3.5. Market Dynamics
3.5.1. drivers
3.5.2. restraints
3.5.3. Opportunities…
3.6. COVID-19 Impact Analysis on the market
In 2021, the United States Food and Drug Administration announced the approval of Tanovea (rabafosadine injection), which is used for the treatment of lymphoma in dogs. In addition, the increase in pet adoption is putting more emphasis on the safety and health of animals, thus driving the growth of the market. According to the American Society for the Prevention of Cruelty to Animals (ASPCA), it has been reported that approximately 4.1 million pets are adopted each year.
♦ 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐈𝐧 𝐏𝐫𝐨𝐜𝐮𝐫𝐢𝐧𝐠 𝐓𝐡𝐢𝐬 𝐑𝐢𝐭? 𝐕𝐢𝐬𝐢𝐭 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/purchase-enquiry/7504
The veterinary oncology market is expected to witness a significant growth in the coming years. This market has gained interest in the healthcare and medical sectors owing to increased prevalence of hypertension throughout the globe. Furthermore, the global veterinary oncology market is segmented on the basis of product type, end user, and region. Leading market players have been introducing various strategies to help enterprises move their on-premise models to on-demand models.
Frequently Asked Questions?
Q1 What is the total market value of veterinary oncology market report?
Q2. Which are the top companies holding the market share in veterinary oncology market?
Q3 Which are the largest regions for this market?
Q4 What is the leading technology of veterinary oncology market?
Q5. What are the major drivers for this specific market?
Q6. What are the upcoming key trends in the veterinary oncology market report?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirm maximum accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
You just read:
News Provided By
October 21, 2022, 14:30 GMT
A Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. A Presswire, Everyone’s Internet News Presswire™, tries to define some of the boundaries that are reasonable in today’s world. Please see our Editorial Guidelines for more information.
Submit your press release